Pricing Log in Create free account

Gossamer Bio, Inc. (GOSS) vs Telomir Pharmaceuticals, Inc. (TELO)

Gossamer Bio, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Gossamer Bio, Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($57.6M and $57.5M). Telomir Pharmaceuticals, Inc. has the higher net margin (0.00% vs −235.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Telomir Pharmaceuticals, Inc. leads on 7 and Gossamer Bio, Inc. on 4.

Valuation

Metric GOSS TELO Biotechnology median
P/E n/m n/m 10.60
P/S 0.73 n/m 9.40
P/B n/m 8.82 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.07 n/m 9.02
Earnings yield (467.69%) (124.66%) (32.88%)
Free cash flow yield (417.17%) (11.07%) (23.13%)

Profitability

Metric GOSS TELO Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (311.70%) 0.00% 0.00%
Net margin (235.00%) 0.00% 0.00%
Free cash flow margin (305.19%) 0.00% 0.00%
Return on equity 178.72% (1,885.50%) (51.96%)
Return on assets (78.81%) (1,678.31%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOSS TELO Biotechnology median
Revenue growth (TTM) 32.43% — 6.76%
EPS growth (last fiscal year) (200.00%) 41.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GOSS TELO Biotechnology median
Debt to equity (0.38) 0.03 0.00
Current ratio 0.53 16.14 4.97
Net debt to EBITDA (0.35) 0.69 1.01

Dividend

Metric GOSS TELO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GOSS TELO Biotechnology median
Market cap 57.56m 57.48m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack